Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 16

1.

Evidence that methylphenidate enhances the saliency of a mathematical task by increasing dopamine in the human brain.

Volkow ND, Wang GJ, Fowler JS, Telang F, Maynard L, Logan J, Gatley SJ, Pappas N, Wong C, Vaska P, Zhu W, Swanson JM.

Am J Psychiatry. 2004 Jul;161(7):1173-80.

PMID:
15229048
2.

Role of dopamine in the therapeutic and reinforcing effects of methylphenidate in humans: results from imaging studies.

Volkow ND, Fowler JS, Wang GJ, Ding YS, Gatley SJ.

Eur Neuropsychopharmacol. 2002 Dec;12(6):557-66. Review.

PMID:
12468018
3.

Variables that affect the clinical use and abuse of methylphenidate in the treatment of ADHD.

Volkow ND, Swanson JM.

Am J Psychiatry. 2003 Nov;160(11):1909-18. Review.

PMID:
14594733
4.

Pharmacokinetic and pharmacodynamic properties of stimulants: implications for the design of new treatments for ADHD.

Swanson JM, Volkow ND.

Behav Brain Res. 2002 Mar 10;130(1-2):73-8. Review.

PMID:
11864720
5.

Does chirality matter? pharmacodynamics of enantiomers of methylphenidate in patients with attention-deficit/hyperactivity disorder.

Quinn D.

J Clin Psychopharmacol. 2008 Jun;28(3 Suppl 2):S62-6. doi: 10.1097/JCP.0b013e3181744aa6. Review.

PMID:
18480679
6.

Imaging the effects of methylphenidate on brain dopamine: new model on its therapeutic actions for attention-deficit/hyperactivity disorder.

Volkow ND, Wang GJ, Fowler JS, Ding YS.

Biol Psychiatry. 2005 Jun 1;57(11):1410-5. Epub 2005 Jan 12. Review.

PMID:
15950015
7.
8.

[Neuropsychiatric bases of the methylphenidate-therapy of the attention deficit/hyperactivity disorder (ADHD)].

Huber M, Kirchler E, Niederhofer H, Gruber L.

Fortschr Neurol Psychiatr. 2007 May;75(5):275-84. Epub 2006 Nov 17. Review. German.

PMID:
17443438
9.

Effects of methylphenidate on the catecholaminergic system in attention-deficit/hyperactivity disorder.

Wilens TE.

J Clin Psychopharmacol. 2008 Jun;28(3 Suppl 2):S46-53. doi: 10.1097/JCP.0b013e318173312f. Review.

PMID:
18480677
10.
11.

A review of the biological bases of ADHD: what have we learned from imaging studies?

Durston S.

Ment Retard Dev Disabil Res Rev. 2003;9(3):184-95. Review.

PMID:
12953298
12.

The dopamine transporter and attention-deficit/hyperactivity disorder.

Madras BK, Miller GM, Fischman AJ.

Biol Psychiatry. 2005 Jun 1;57(11):1397-409. Epub 2005 Jan 5. Review.

PMID:
15950014
13.

The roles of dopamine and noradrenaline in the pathophysiology and treatment of attention-deficit/hyperactivity disorder.

Del Campo N, Chamberlain SR, Sahakian BJ, Robbins TW.

Biol Psychiatry. 2011 Jun 15;69(12):e145-57. doi: 10.1016/j.biopsych.2011.02.036. Epub 2011 May 6. Review.

PMID:
21550021
15.

Positron emission tomography neuroimaging for a better understanding of the biology of ADHD.

Zimmer L.

Neuropharmacology. 2009 Dec;57(7-8):601-7. doi: 10.1016/j.neuropharm.2009.08.001. Epub 2009 Aug 13. Review.

PMID:
19682469
16.

Methylphenidate and the juvenile brain: enhancement of attention at the expense of cortical plasticity?

Urban KR, Gao WJ.

Med Hypotheses. 2013 Dec;81(6):988-94. doi: 10.1016/j.mehy.2013.09.009. Epub 2013 Sep 17. Review.

Supplemental Content

Support Center